Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
CNS Pharmaceuticals Inc
CNSP
Healthcare
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system (CNS). The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for...
the treatment of a number of serious brain and CNS oncology indications, including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. In addition, the Company is advancing the development of its WP1244/WP1874 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents. The Company is also evaluating the use of WP1244/WP1874 in the treatment of other primary brain and central nervous system cancers, as well as cancers metastatic to the brain including pancreatic, ovarian, and lymphomas.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CNSP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(280)
•••
whytestocks
X
Post by
whytestocks
on Nov 18, 2024 12:30pm
CNS Pharmaceuticals Announces Abstract Accepted for Poster P
NEWS: $CNSP CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)HOUSTON, TX / ACCESSWIRE / November 18, 2024
...more
(280)
•••
whytestocks
X
Post by
whytestocks
on Nov 08, 2024 8:15pm
New Graphene Chip Could Revolutionize Brain Cancer Treatment
BREAKING NEWS: $CNSP New Graphene Chip Could Revolutionize Brain Cancer TreatmentResearchers have developed a chip that may revolutionize how brain cancer is treated. This revolutionary device is made
...more
(280)
•••
whytestocks
X
Post by
whytestocks
on Aug 22, 2024 1:30pm
InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ:
NEWS: $CNSP InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Upcoming Virtual Investor CEO Connect SegmentCNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical
...more
(280)
•••
whytestocks
X
Post by
whytestocks
on Aug 15, 2024 6:15pm
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Re
NEWS: $CNSP CNS Pharmaceuticals Reports Second Quarter 2024 Financial ResultsPotentially pivotal GBM study evaluating lead program, Berubicin, enrollment completed; Topline data expected in the first
...more
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 2:02am
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) – A Promising
https://beyondspx.com/2024/08/02/cns-pharmaceuticals-inc-nasdaqcnsp-a-promising-oncology-play-with-significant-upside-potential/
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 03, 2024 11:28am
RE:CNSP....P.O just announced....you've all been had...Again !
Wortha Repeat.....Hell ya All the Chasers are buried ....again !!!!
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 14, 2024 3:20pm
CNSP....P.O just announced....you've all been had...Again !
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement 2024-06-14 12:13 ET - News Release HOUSTON, TX / ACCESSWIRE / June
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on May 08, 2023 8:47am
New Press Release - Bettina M. Cockroft, M.D., M.B.A., Pharmaceutical and Biotech Industry Veteran, Joins CNS Pharmaceuticals Board of Directors
Brings over 30 years of significant biopharmaceutical industry experience and proven clinical development and operational expertise across multiple therapeutic disciplines worldwideHOUSTON, TX / ACCESSWIRE / May 8, 2023 /CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 03, 2023 8:47am
New Press Release - CNS Pharmaceuticals Investigating Potential Naked Short Selling; Retains Shareholder Intelligence Services, LLC
HOUSTON, TX / ACCESSWIRE / May 3, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that it is...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 27, 2023 8:46am
New Press Release - CNS Pharmaceuticals to Present at the Virtual Investor Spotlight Event - Rapidly Advancing GBM Pivotal Study
Live moderated video webcast with members of CNS Pharmaceuticals management on Wednesday, May 3rd at 12:00 PM ETHOUSTON, TX / ACCESSWIRE / April 27, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel...
read article.
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2023 5:57pm
CNSP..... 9.0 mil shs have traded in AH
Last at $2.90 Who knows where this will close and also where it will open on Monday I've been burnt a few times holding these Shitco's....then again I've been lucky to....mostly burnt
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2023 5:01pm
CNSP ....crash booom bang
What a dump....7.9 mill shs traded last at ...... $3.05
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2023 4:17pm
CNSP..... This is why I seldom trade AH or PM trading
The share price is soooooo volatile and us Cdn's have to pay full commish CNSP has traded 3.6 million shs in AH now at $4.05
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2023 4:11pm
CNSP 2.7 mil shs traded in AH
last at 3.29
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2023 4:09pm
CNSP...... Holy cr8p !!!!
Halted at 52 mins before the closing bell.... now everyone is trapped Now resumed trading in After hours trading almost 1.5 million shs traded last at $3,70 Now u get to pay Full commissions
...more
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Are PGM mining stocks an attractive area for your next portfolio allocation?
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities